金活醫藥集團(01110.HK)盈喜:2021年股東應占溢利預增155%-160%
格隆匯3月23日丨金活醫藥集團(01110.HK)公佈,集團預期截至2021年12月31日止年度的公司擁有人應占溢利將較截至2020年12月31日止年度的公司擁有人應占溢利人民幣1170萬元增加約155%至160%。
董事會認為公司擁有人應占溢利增加主要是由於COVID-19疫情受到控制,使市場在2021年度相對前年度有所復甦。致從事品牌進口醫藥及保健產品的中國分銷業務的(i)收益增加約45%至50%;及(ii)毛利增加約65%至70%。
公司非全資附屬深圳市東迪欣科技有限公司,一家生產各種醫療設備(包括紅外線探熱器)的醫療設備製造商,並已為其製造的醫療設備取得各項證書及許可證,預期2021年度的年度溢利將較前年度減少約34%至39%主要是由於抗疫情設備的銷售有所回落所致。
基於上文所述,集團預期2021年度的集團年度溢利將較前年度的集團年度溢利人民幣5090萬元增加約1%至5%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.